These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35790285)

  • 1. The Casein Kinase 2 Inhibitor CX-4945 Promotes Cholangiocarcinoma Cell Death Through PLK1.
    Lee DS; Lee S; Kim C; Kim D; Kim KP; Yoo C
    Anticancer Res; 2022 Jul; 42(7):3435-3443. PubMed ID: 35790285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α.
    Wang S; Yadav AK; Han JY; Ahn KS; Jang BC
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35683032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CX-4945 (Silmitasertib) Induces Cell Death by Impairing Lysosomal Utilization in
    Lee DS; Han MW; Kang Y; Kim C; Lee S; Kim KP; Yoo C
    Anticancer Res; 2024 May; 44(5):1939-1946. PubMed ID: 38677763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BI6727 and GSK461364A, potent PLK1 inhibitors induce G2/M arrest and apoptosis against cholangiocarcinoma cell lines.
    Riantana H; Waenphimai O; Mahalapbutr P; Karnchanapandh K; Vaeteewoottacharn K; Wongkham S; Sawanyawisuth K
    Pathol Res Pract; 2023 Aug; 248():154678. PubMed ID: 37454493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silmitasertib, a casein kinase 2 inhibitor, induces massive lipid droplet accumulation and nonapoptotic cell death in head and neck cancer cells.
    Su YW; Huang WY; Lin HC; Liao PN; Lin CY; Lin XY; Huang SH; Chen YT; Wu PS
    J Oral Pathol Med; 2023 Mar; 52(3):245-254. PubMed ID: 36273268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer.
    Bian Y; Han J; Kannabiran V; Mohan S; Cheng H; Friedman J; Zhang L; VanWaes C; Chen Z
    Int J Biol Sci; 2015; 11(4):411-22. PubMed ID: 25798061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatment.
    Zhou Y; Xu L; Wang Z; Liu H; Zhang X; Shu C; Zhang M; Wang T; Xu X; Pu X; He J; Wang P; Qiu Y; Xu G; Zou X; Zhu Y; Wang L
    Theranostics; 2022; 12(8):3911-3927. PubMed ID: 35664077
    [No Abstract]   [Full Text] [Related]  

  • 8. Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells.
    Sydor S; Jafoui S; Wingerter L; Swoboda S; Mertens JC; Gerken G; Canbay A; Paul A; Fingas CD
    World J Gastroenterol; 2017 Jun; 23(22):4007-4015. PubMed ID: 28652654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Condensed tannins from Ulmus pumila L. leaves induce G2/M phase arrest and apoptosis via caspase-cascade activation in TFK-1 cholangiocarcinoma cells.
    Ren Y; Qin Z; Wang Z; Wei S; Chen H; Zhu T; Liu L; Zhao Y; Ding B; Song W
    J Food Biochem; 2022 Oct; 46(10):e14374. PubMed ID: 35986624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism.
    Lertsuwan J; Lertsuwan K; Sawasdichai A; Tasnawijitwong N; Lee KY; Kitchen P; Afford S; Gaston K; Jayaraman PS; Satayavivad J
    Cancers (Basel); 2018 Aug; 10(9):. PubMed ID: 30142881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT/mTOR down-regulation by CX-4945, a CK2 inhibitor, promotes apoptosis in chemorefractory non-small cell lung cancer cells.
    So KS; Rho JK; Choi YJ; Kim SY; Choi CM; Chun YJ; Lee JC
    Anticancer Res; 2015 Mar; 35(3):1537-42. PubMed ID: 25750308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cells.
    Silva-Pavez E; Villar P; Trigo C; Caamaño E; Niechi I; Pérez P; Muñoz JP; Aguayo F; Burzio VA; Varas-Godoy M; Castro AF; Colombo MI; Tapia JC
    Cell Death Dis; 2019 Jan; 10(2):73. PubMed ID: 30683840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLK1 inhibition leads to mitotic arrest and triggers apoptosis in cholangiocarcinoma cells.
    Moolmuang B; Chaisaingmongkol J; Singhirunnusorn P; Ruchirawat M
    Oncol Lett; 2024 Jul; 28(1):316. PubMed ID: 38807667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZD1839 (IRESSA) stabilizes p27Kip1 and enhances radiosensitivity in cholangiocarcinoma cell lines.
    Yabuuchi S; Katayose Y; Oda A; Mizuma M; Shirasou S; Sasaki T; Yamamoto K; Oikawa M; Rikiyama T; Onogawa T; Yoshida H; Ohtuska H; Motoi F; Egawa S; Unno M
    Anticancer Res; 2009 Apr; 29(4):1169-80. PubMed ID: 19414361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoplasmic Reticulum Stress-Mediated Apoptosis Induced by VR12684 Isolated from Mallotus spodocarpus in Cholangiocarcinoma Cell Line.
    Hahnvajanawong C; Puthabaln W; Boonmars T; Reutrakul V; Boueroy P
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2741-2748. PubMed ID: 37642060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.
    Zhao B; Zhao H; Zhao N; Zhu XG
    J Hepatobiliary Pancreat Surg; 2002; 9(4):497-502. PubMed ID: 12483273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.
    Wang Z; Tang X; Zhang Y; Qi R; Li Z; Zhang K; Liu Z; Yang X
    Biomed Pharmacother; 2012 Apr; 66(3):161-6. PubMed ID: 22425181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells.
    Ke F; Wang Z; Song X; Ma Q; Hu Y; Jiang L; Zhang Y; Liu Y; Zhang Y; Gong W
    Drug Des Devel Ther; 2017; 11():1753-1766. PubMed ID: 28670110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo.
    Richter A; Sender S; Lenz A; Schwarz R; Hinz B; Knuebel G; Sekora A; Murua Escobar H; Junghanss C; Roolf C
    BMC Cancer; 2020 Mar; 20(1):184. PubMed ID: 32131762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma.
    Li Y; Zhao ZG; Luo Y; Cui H; Wang HY; Jia YF; Gao YT
    World J Gastroenterol; 2020 Aug; 26(32):4786-4801. PubMed ID: 32921957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.